Literature DB >> 26045766

Immunity of fungal infections alleviated graft reject in liver transplantation compared with non-fungus recipients.

Tonghai Xing1, Lin Zhong1, Lihui Lin2, Guoqiang Qiu1, Zhihai Peng1.   

Abstract

OBJECTIVE: To evaluate of the immune tolerance in adult LT recipients with Invasive fungal infections (IFIs).
METHODS: 109 consecutive LT recipients who received LT were included. Percentage of T subsets (CD4+CD25hiCD127- T cells, CD4+CD25loCD45RA+ T cells, CD4+CD25loCD45RA- and CD4+CD45RA-CD45RO+ T cells populations), levels of cytokines (IL-1b, IL-2, IL-4, IL-6, IL-8, IL-10, IFN-γ, IL-12p70, IL-17, TNF-α, TNF-β and GM-CSF) were detected by FACS and Bioplex in peripheral blood. Biopsy specimens were fixed, monoclonal antibodies against CD4, Foxp3 and IL-17 were applied to the above sections and FISH was performed.
RESULTS: The risk of acute rejection was decreased in fungal infected liver transplant recipients comparing with non-fungal infected group. CD4+CD25hiCD127T cell population was increased in peripheral blood and memory CD4+CD45RA-CD45RO+ T cell population decreased. There was significant lower levels observed in naïve CD4+CD25loCD45RA+ and CD4+CD25loCD45RA- T cell populations in fungal infected liver transplant. Moreover, IL-2, IL-6, IL-10 and GM-CSF were decreased. However, no significant difference with IL-4 and IL-8 in serum in two infected LT recipients.
CONCLUSION: The incidence of graft rejection in liver transplantation recipients with fungal infections was lower than the non-fungal group. It is important to assess the risk during pretransplant and postoperation for liver transplantation.

Entities:  

Keywords:  Graft rejection; T cell subsets; cytokines; fungal infections; liver transplantation

Mesh:

Substances:

Year:  2015        PMID: 26045766      PMCID: PMC4440075     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  20 in total

1.  Outcomes of antifungal prophylaxis in high-risk liver transplant recipients.

Authors:  S Hadley; C Huckabee; P G Pappas; J Daly; J Rabkin; C A Kauffman; R M Merion; A W Karchmer
Journal:  Transpl Infect Dis       Date:  2008-12-19       Impact factor: 2.228

2.  Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients.

Authors:  Roniel Cabrera; Miguel Ararat; Consuelo Soldevila-Pico; Lisa Dixon; Jen-Jung Pan; Roberto Firpi; Victor Machicao; Cynthia Levy; David Nelson; Giuseppe Morelli
Journal:  Liver Transpl       Date:  2009-02       Impact factor: 5.799

3.  Vitamin D3 modulates T lymphocyte responses in hepatitis C virus-infected liver transplant recipients.

Authors:  Cristiana Almerighi; Alberto Bergamini; Raffaella Lionetti; Anna Sinistro; Ilaria Lenci; Laura Tariciotti; Giuseppe Tisone; Mario Angelico
Journal:  Dig Liver Dis       Date:  2011-09-17       Impact factor: 4.088

4.  Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).

Authors:  Peter G Pappas; Barbara D Alexander; David R Andes; Susan Hadley; Carol A Kauffman; Alison Freifeld; Elias J Anaissie; Lisa M Brumble; Loreen Herwaldt; James Ito; Dimitrios P Kontoyiannis; G Marshall Lyon; Kieren A Marr; Vicki A Morrison; Benjamin J Park; Thomas F Patterson; Trish M Perl; Robert A Oster; Mindy G Schuster; Randall Walker; Thomas J Walsh; Kathleen A Wannemuehler; Tom M Chiller
Journal:  Clin Infect Dis       Date:  2010-04-15       Impact factor: 9.079

5.  Evaluating the effects of immunosuppressants on human immunity using cytokine profiles of whole blood.

Authors:  Zhanguo Liu; Xiaopeng Yuan; Yuwei Luo; Yi He; Yong Jiang; Zhonghua Klauz Chen; Erwei Sun
Journal:  Cytokine       Date:  2009-01-09       Impact factor: 3.861

6.  Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients.

Authors:  Jesus Fortún; Pilar Martín-Dávila; Miguel Montejo; Patricia Muñoz; José M Cisneros; Antonio Ramos; Cesar Aragón; Marino Blanes; Rafael San Juan; Joan Gavaldá; Pedro Llinares
Journal:  Transplantation       Date:  2009-02-15       Impact factor: 4.939

7.  ImmuKnow: a new parameter in immune monitoring of pediatric liver transplantation recipients.

Authors:  Moshe Israeli; Tirza Klein; Benjamin Sredni; Yaron Avitzur; Eitan Mor; Nathan Bar-Nathen; Ran Steinberg; Gabriel Dinari; Rivka Shapiro
Journal:  Liver Transpl       Date:  2008-06       Impact factor: 5.799

8.  Preceeding the rejection: in search for a comprehensive post-transplant immune monitoring platform.

Authors:  Moshe Israeli; Alex Yussim; Eitan Mor; Benjamin Sredni; Tirza Klein
Journal:  Transpl Immunol       Date:  2007-04-09       Impact factor: 1.708

9.  Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients.

Authors:  Alan Reed; Jill Boylston Herndon; Nail Ersoz; Takahisa Fujikawa; Denise Schain; Paul Lipori; Alan Hemming; Qin Li; Elizabeth Shenkman; Bruce Vogel
Journal:  Liver Transpl       Date:  2007-12       Impact factor: 5.799

10.  Regeneration of graft livers and limited contribution of extrahepatic cells after partial liver transplantation in humans.

Authors:  Susumu Eguchi; Mitsuhisa Takatsuki; Kosho Yamanouchi; Yukio Kamohara; Yoshitsugu Tajima; Takashi Kanematsu
Journal:  Dig Dis Sci       Date:  2009-03-19       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.